Showing results (71-80 of 80) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Journal of Medicinal Chemistry|October 13, 2006
Small-molecule inhibitors of the MDM2-p53 protein-protein interaction based on an isoindolinone scaffoldIan R Hardcastle, Shafiq U Ahmed, Helen Atkins, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumorsSean Carlin, Rob J Mairs, Anthony G McCluskey, et al.Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interactionIan R Hardcastle, Shafiq U Ahmed, Helen Atkins, et al.Scientific Reports|August 19, 2021
Key features of the environment promoting liver cancer in the absence of cirrhosisMarco Youssef William Zaki, Ahmed Khairallah Mahdi, Gillian Lucinda Patman, et al.Journal of Medicinal Chemistry|February 15, 2011
Isoindolinone inhibitors of the murine double minute 2 (MDM2)-p53 protein-protein interaction: structure-activity studies leading to improved potencyIan R Hardcastle, Junfeng Liu, Eric Valeur, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
A multilocus technique for risk evaluation of patients with neuroblastomaInge M Ambros, Bettina Brunner, Gerhard Aigner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2020
Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable <i>MYCN</i>-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation GroupInge M Ambros, Gian-Paolo Tonini, Ulrike Pötschger, et al.Journal of Medicinal Chemistry|March 24, 2021
Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein-Protein InteractionGianni Chessari, Ian R Hardcastle, Jong Sook Ahn, et al.Nature Communications|May 24, 2018
Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockageMarcus J G W Ladds, Ingeborg M M van Leeuwen, Catherine J Drummond, et al.Nature Communications|March 18, 2018
A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockageMarcus J G W Ladds, Ingeborg M M van Leeuwen, Catherine J Drummond, et al.Pageof 8